Live Breaking News & Updates on Vivopharm Global Preclinical Services

Stay updated with breaking news from Vivopharm global preclinical services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Immuron Clinical Trials Update

Highlights: US Naval Medical Research Command campylobacter clinical program completes in-patient phase Manufacture of IMM-529 drug substance to support the Pre-IND information package has been. ....

United States , South Australia , Johns Hopkins University , Mohamed Al Ibrahim , Steven Lydeamore , Kawsar Talaat , Immuron Limited , Monash University , Animal Ethics Committee , Drug Administration , Us Naval Medical Research Command , Vivopharm Global Preclinical Services , Clinical Research Facility Inpatient Unit , Immunization Research , Medical Research Command , Principal Investigator Dr Kawsar Talaat , Inpatient Unit , Medical Campus , Investigational Medical Product , Clostridioides Difficile , Principal Investigator Dr Mohamed Al Ibrahim ,

Immuron Limited Clinical Trials Update

Immuron Limited provided shareholders and the market with an update on the company s clinical development portfolio. The NMRC has recently completed the in-patient stage of the campylobacter challenge. ....

Johns Hopkins University , United States , Kawsar Talaat , Animal Ethics Committee , Immunization Research , Monash University , Vivopharm Global Preclinical Services , Drug Administration , Immuron Limited , Principal Investigator , Inpatient Unit , Medical Campus , Investigational Medical Product , Clostridioides Difficile ,